Skip to content
OpenCapital
Get started

Turn Therapeutics Inc. TTRX Q3 2025 earnings

Reported November 13, 2025 · Before market open

Diluted EPS-$0.07

Next report

Sep 2, 2026 (in 2 months)
EPS estimate-$0.02

Financials

Q3 2025

Income statement

See full
Operating income-$1.9M-184%
Net income-$1.9M-186%
EPS (diluted)-$0.07-133%

Balance sheet

See full
Cash & equivalents$3.1M+294%
Total debt$91.2K—
Total equity$504.0K+222%
Total assets$4.3M—

Versus estimates

Diluted EPS

Q1 2026-$0.03Miss by $0.01Q4 2025-$0.09Miss by $0.04
Q3 2025-$0.07

Ask the moment Turn Therapeutics Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Turn Therapeutics Inc. report Q3 2025 earnings?
Turn Therapeutics Inc. (TTRX) reported Q3 2025 earnings on November 13, 2025 before market open.
What were Turn Therapeutics Inc.'s Q3 2025 revenue and EPS?
Turn Therapeutics Inc. reported diluted EPS of $-0.07 for Q3 2025.
Where can I find Turn Therapeutics Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001213900-25-108655) and the 10-Q periodic report (0001213900-25-109586) directly on SEC EDGAR. The filing index links above go to sec.gov.